Accueil   Diary - News   All news Alizé Pharma launches Phase II clinical trial

Alizé Pharma launches Phase II clinical trial

Alizé Pharma, a company specialized in the development of drugs for the treatment of metabolic disorders and rare diseases, today announces the launch of a Phase II clinical trial of AZP-531, its unacylated ghrelin analog, in patients with Prader-Willi syndrome.

 

Read the press release